Activation of microglia with zymosan promotes excitatory amino acid release via volume-regulated anion channels: the role of NADPH oxidases
FDAs 2026 BPC-157 briefing document also described a spontaneous adverse-event report involving a product labelled BPC-157 plus TB-500
Nuclear proteomics uncovers diurnal regulatory landscapes in mouse liver
Receptor activation can be maintained for the duration of the experiment without dosing complexity

Water, Glycerin, Caprylic/Capric Triglyceride, Butylene Glycol, Methylpropanediol, Niacinamide, Tranexamic Acid, Dipropylene Glycol, Phenyl Trimethicone, 1,2-Hexanediol, Butyrospermum Parkii (Shea) Butter, Cetearyl Alcohol, Dicaprylyl Carbonate, Polyglyceryl-2 Stearate, Polysorbate 60, Glyceryl Stearate, Stearyl Alcohol, Sorbitan Sesquioleate, Sodium Polyacrylate, Stearic Acid, Lactose, Ammonium Acryloyldimethyltaurate / VP Copolymer, Microcrystalline Cellulose, Palmitic Acid, Betaine, Caprylic/Capric Triglyceride, Ethylhexylglycerin, Sodium Acrylate/Sodium Acryloyldimethyl Taurate Copolymer, Propanediol, Allantoin, Adenosine, Polyisobutene, Tocopherol, Hydrogenated Lecithin, Disodium EDTA, Astaxanthin, CI 77491, Tocopheryl Acetate, Phytosteryl/Octyldodecyl Lauroyl Glutamate, Arachidic Acid, Caprylyl / Capryl Glucoside, Sorbitan Oleate, Ceramide NP, Eriobotrya Japonica Leaf Extract, Theobroma Cacao (Cocoa) Extract, Myristic Acid, Oleic Acid, Glutathione, Hydroxypropyl Methylcellulose, Mentha Viridis (Spearmint) Extract, CI 14700, Ascorbic Acid, Sodium Hyaluronate, Dextrin
